Siegfried Holding Ltd (SFZN.SW) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Siegfried Holding Ltd

SFZN.SW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Siegfried Holding is a Swiss contract manufacturer that develops and produces active pharmaceutical ingredients and finished drug products for other pharmaceutical companies. Its work spans custom chemical synthesis, sterile fill-and-finish, inhalation and oral dosage forms, and manufacturing of viral vectors for gene therapy. It is based in Zofingen, Switzerland, and operates as an outsourced production partner to drugmakers worldwide.
Where it sits in the stack
Siegfried holds no seat in Rubin, our AI compute index, or in Halo; it sits outside the diary's AI-linked sleeves entirely. It is tracked instead as a pharmaceutical contract manufacturer within the healthcare sector of our wider universe, not against any build-out layer.
Who it is priced against
Closelook's peer group holds no comparison set for this name. The market most often sets it beside Lonza, the larger contract manufacturer active in similar drug-substance and drug-product work.
Why Closelook tracks it
Siegfried carries no index seat and no Closelook score; the score-building process has not started for this name. The diary has not quoted it in any edition so far, and it appears in no Rubin or Halo reading.
What the diary watches
The diary watches whether demand for gene-therapy and viral-vector manufacturing capacity keeps rising, since that would test how a contract manufacturer scales its production alongside larger pharmaceutical clients.

Siegfried Holding Ltd (SFZN.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelook company score reads 42/100 composite (momentum 36, quality 42, valuation 55) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for SFZN.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · Switzerland · 5 names with week and year-to-date

Peer group

Healthcare · Switzerland

Scored names in the same sector and country from the Closelook universe.

Compared against SFZN.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Siegfried Holding Ltd (SFZN.SW)?

Siegfried Holding Ltd trades as SFZN.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is SFZN.SW in a Closelook index?

Not currently — Siegfried Holding Ltd is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is Siegfried Holding Ltd's Closelook composite score?

42 out of 100, with momentum 36, quality 42 and valuation 55 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does SFZN.SW trade against its moving averages?

Downtrend stack: Trades -0.3% vs the 50-day and -4.8% vs the 200-day average, 26.6% below the 52-week high and +14.1% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Siegfried Holding Ltd do?

Siegfried Holding is a Swiss contract manufacturer that develops and produces active pharmaceutical ingredients and finished drug products for other pharmaceutical companies. Its work spans custom chemical synthesis, sterile fill-and-finish, inhalation and oral dosage forms, and manufacturing of viral vectors for gene therapy. It is based in Zofingen, Switzerland, and operates as an outsourced production partner to drugmakers worldwide. Closelook's peer group holds no comparison set for this name. The market most often sets it beside Lonza, the larger contract manufacturer active in similar drug-substance and drug-product work.

Where does Siegfried Holding Ltd sit in the AI build-out?

Siegfried holds no seat in Rubin, our AI compute index, or in Halo; it sits outside the diary's AI-linked sleeves entirely. It is tracked instead as a pharmaceutical contract manufacturer within the healthcare sector of our wider universe, not against any build-out layer. Siegfried carries no index seat and no Closelook score; the score-building process has not started for this name. The diary has not quoted it in any edition so far, and it appears in no Rubin or Halo reading.

What does this page show?

A live price chart with SMA overlays and drawing tools for SFZN.SW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe